Variability is the enemy of good outcomes. Across healthcare, inconsistent diagnosis, fragmented workflows, and uneven adherence to guidelines continue to drive delays in treatment and unnecessary cost.
Download this essential report to understand how AI Care Pathways are standardizing evidence-based care at the point of care, and how leading pharma organizations are moving from downstream support to upstream engagement to achieve measurable impact.
What You Will Learn
- AI is Reshaping Clinical Decision-Making: See the stats on how 67% of physicians are using AI daily and why it’s moving beyond administrative relief to decision support and diagnostics.
- The Structural Shift for Pharma: Explore the three highest-impact AI categories for pharma leaders (AI Clinical Co-Pilots, Adherence Optimization, and Workflow-Embedded Engagement) and why the focus must move to earlier identification and pathway selection.
- The Three-Partner Model for Scale: Discover how pharma, health systems, and technology partners (like Viz.ai) must align to turn AI from pilots into clinical reality, driving outcomes such as earlier patient identification and reduced variation in care delivery.
- From Pilots to Infrastructure: Understand the three defining characteristics of effective AI solutions—Embedded by Design, Focused on Low-Cognition/High-Friction Work, and Transparent and Verifiable—to ensure sustainable, ecosystem-level coordination.
